These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 37509471)
1. Clinical Results of Transarterial Radioembolization (TARE) with Holmium-166 Microspheres in the Multidisciplinary Oncologic Treatment of Patients with Primary and Secondary Liver Cancer. Drescher R; Köhler A; Seifert P; Aschenbach R; Ernst T; Rauchfuß F; Freesmeyer M Biomedicines; 2023 Jun; 11(7):. PubMed ID: 37509471 [TBL] [Abstract][Full Text] [Related]
2. Clinical Results of Holmium-166 Radioembolization with Personalized Dosimetry for the Treatment of Hepatocellular Carcinoma. Kühnel C; Köhler A; Brachwitz T; Seifert P; Gühne F; Aschenbach R; Freudenberg R; Freesmeyer M; Drescher R J Pers Med; 2024 Jul; 14(7):. PubMed ID: 39064001 [TBL] [Abstract][Full Text] [Related]
3. Holmium-166 Transarterial Radioembolization for the Treatment of Intrahepatic Cholangiocarcinoma: A Case Series. Vermeulen S; De Keukeleire K; Dorny N; Colle I; Van Den Bossche B; Nuttens V; Ooms D; De Bondt P; De Winter O Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835485 [TBL] [Abstract][Full Text] [Related]
4. Intraprocedural MRI-based dosimetry during transarterial radioembolization of liver tumours with holmium-166 microspheres (EMERITUS-1): a phase I trial towards adaptive, image-controlled treatment delivery. Roosen J; Westlund Gotby LEL; Arntz MJ; Fütterer JJ; Janssen MJR; Konijnenberg MW; van Wijk MWM; Overduin CG; Nijsen JFW Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4705-4715. PubMed ID: 35829749 [TBL] [Abstract][Full Text] [Related]
5. Factors impacting survival after transarterial radioembolization in patients with hepatocellular carcinoma: Results from the prospective CIRT study. Kolligs F; Arnold D; Golfieri R; Pech M; Peynircioglu B; Pfammatter T; Ronot M; Sangro B; Schaefer N; Maleux G; Munneke G; Pereira H; Zeka B; de Jong N; Helmberger T; JHEP Rep; 2023 Feb; 5(2):100633. PubMed ID: 36593888 [TBL] [Abstract][Full Text] [Related]
6. TheraSphere Yttrium-90 Glass Microspheres Combined With Chemotherapy Versus Chemotherapy Alone in Second-Line Treatment of Patients With Metastatic Colorectal Carcinoma of the Liver: Protocol for the EPOCH Phase 3 Randomized Clinical Trial. Chauhan N; Mulcahy MF; Salem R; Benson Iii AB; Boucher E; Bukovcan J; Cosgrove D; Laframboise C; Lewandowski RJ; Master F; El-Rayes B; Strosberg JR; Sze DY; Sharma RA JMIR Res Protoc; 2019 Jan; 8(1):e11545. PubMed ID: 30664496 [TBL] [Abstract][Full Text] [Related]
7. Factors Impacting Survival After Transarterial Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: A Combined Analysis of the Prospective CIRT Studies. Reimer P; Vilgrain V; Arnold D; Balli T; Golfieri R; Loffroy R; Mosconi C; Ronot M; Sengel C; Schaefer N; Maleux G; Munneke G; Peynircioglu B; Sangro B; Kaufmann N; Urdaniz M; Pereira H; de Jong N; Helmberger T Cardiovasc Intervent Radiol; 2024 Mar; 47(3):310-324. PubMed ID: 38321223 [TBL] [Abstract][Full Text] [Related]
8. Improving MRI-based dosimetry for holmium-166 transarterial radioembolization using a nonrigid image registration for voxelwise Roosen J; van Wijk MWM; Westlund Gotby LEL; Arntz MJ; Janssen MJR; Lobeek D; van de Maat GH; Overduin CG; Nijsen JFW Med Phys; 2023 Feb; 50(2):935-946. PubMed ID: 36202392 [TBL] [Abstract][Full Text] [Related]
9. Survival and Toxicities after Emmons EC; Bishay S; Du L; Krebs H; Gandhi RT; Collins ZS; O'Hara R; Akhter NM; Wang EA; Grilli C; Brower JS; Peck SR; Petroziello M; Abdel Aal AK; Golzarian J; Kennedy AS; Matsuoka L; Sze DY; Brown DB Radiology; 2022 Oct; 305(1):228-236. PubMed ID: 35762890 [TBL] [Abstract][Full Text] [Related]
10. Transarterial Radioembolization (TARE) in Patients with Hepatocellular Carcinoma: A Comparison of Palliative with Bridging-to-Transplant Concepts. Schönherr J; Seifert P; Gühne F; Winkens T; Rauchfuß F; Settmacher U; Freesmeyer M; Drescher R Cancers (Basel); 2024 Jan; 16(1):. PubMed ID: 38201662 [TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study. Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511 [TBL] [Abstract][Full Text] [Related]
12. Transarterial Radioembolization of Hepatocellular Carcinoma, Liver-Dominant Hepatic Colorectal Cancer Metastases, and Cholangiocarcinoma Using Yttrium90 Microspheres: Eight-Year Single-Center Real-Life Experience. Pellegrinelli J; Chevallier O; Manfredi S; Dygai-Cochet I; Tabouret-Viaud C; Nodari G; Ghiringhelli F; Riedinger JM; Popoff R; Vrigneaud JM; Cochet A; Aho S; Latournerie M; Loffroy R Diagnostics (Basel); 2021 Jan; 11(1):. PubMed ID: 33466706 [TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant Yttrium-90 Transarterial Radioembolization with Resin Microspheres Prescribed Using the Medical Internal Radiation Dose Model for Intrahepatic Cholangiocarcinoma. Sarwar A; Ali A; Ljuboja D; Weinstein JL; Shenoy-Bhangle AS; Nasser IA; Morrow MK; Faintuch S; Curry MP; Bullock AJ; Ahmed M J Vasc Interv Radiol; 2021 Nov; 32(11):1560-1568. PubMed ID: 34454031 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of results after 112 radioembolizations with Casáns-Tormo I; Guijarro-Rosaleny J; Lluch-García P; Rodríguez-Parra H; Roselló-Keränen S; Asensio-Valero L Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(4):255-264. PubMed ID: 37269983 [TBL] [Abstract][Full Text] [Related]
15. Transarterial Radioembolization Versus Atezolizumab-Bevacizumab in Unresectable Hepatocellular Carcinoma: A Matching-Adjusted Indirect Comparison of Time to Deterioration in Quality of Life. Agirrezabal I; Brennan VK; Colaone F; Shergill S; Pereira H; Chatellier G; Vilgrain V Adv Ther; 2022 May; 39(5):2035-2051. PubMed ID: 35279814 [TBL] [Abstract][Full Text] [Related]
16. Transarterial Radioembolization Planning and Treatment with Microspheres Containing Holmium-166: Determination of Renal and Intestinal Radionuclide Elimination, Effective Half-Life, and Regulatory Aspects. Kühnel C; Gühne F; Seifert P; Freudenberg R; Freesmeyer M; Drescher R Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612062 [TBL] [Abstract][Full Text] [Related]
17. Radioembolization vs sorafenib in locally advanced hepatocellular carcinoma with portal vein tumor thrombosis: A propensity score and Bayesian analysis. Martelletti C; Ricotti A; Gesualdo M; Carucci P; Gaia S; Rolle E; Burlone ME; Okolicsanyi S; Mattalia A; Pirisi M; Berchialla P; Tabone M J Dig Dis; 2021 Aug; 22(8):496-502. PubMed ID: 34189839 [TBL] [Abstract][Full Text] [Related]
18. In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization? El Fouly A; Ertle J; El Dorry A; Shaker MK; Dechêne A; Abdella H; Mueller S; Barakat E; Lauenstein T; Bockisch A; Gerken G; Schlaak JF Liver Int; 2015 Feb; 35(2):627-35. PubMed ID: 25040497 [TBL] [Abstract][Full Text] [Related]
19. Yttrium-90 Radioembolization Therapy for Combined Hepatocellular and Cholangiocarcinoma. Badar W; Van Ha T; Zangan S; Navuluri R; Pillai A; Baker T; Ahmed O Gastrointest Tumors; 2020 Oct; 7(4):144-150. PubMed ID: 33173778 [TBL] [Abstract][Full Text] [Related]
20. Ablative-Transarterial Radioembolization resulting in complete histopathological response of hepatocellular carcinoma in the resected liver specimen after salvage hepatectomy. Chung TK; Leung TW; Chung CH; Leung HH; Lau WY Int J Surg Case Rep; 2022 Jan; 90():106679. PubMed ID: 34972009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]